InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Wapnick Pamela. Director active across 2 companies, notably Metagenomi, Inc.. In total, 10 filings have been recorded. Split: 0 buy · 7 sells. Total volume traded: €32k. Activity tracked since 1 April 2024. The latest transaction was filed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Pamela Wapnick is an insider linked to Metagenomi, Inc. and Metagenomi Therapeutics, Inc., where she is Chief Financial Officer. She has 10 filings in total, and across the 10 sampled filings between 2024-04-03 and 2026-04-03, the amounts show 0 in buys and 31614 in sells, with Cession as the dominant transaction nature.